SRAX (NASDAQ: SRAX) founder Chris Miglino was featured in a recent LA Weekly Weekly Podcast with Brian Calle to discuss the topic of big data and SRAX’s capabilities in giving power to the individual. “We created a platform that puts the power of the data back in the hands of the consumer,” Miglino said during…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly owned subsidiary of the company, subscribed for 2,380,952 units of James E. Wagner Cultivation Corp. (“JWC”) (TSX.V: JWCA) (OTCQX: JWCAF) at a price of $0.21 each for total consideration of approximately $500,000 in…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced its February 4, 2020 receipt of notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the company has regained compliance with the minimum bid price requirement under Nasdaq Listing…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced the launch of a new educational product, “Smart Screen Immersive Education Classes,” that will be implemented in preschools in Fujian, China. According to the update, the classes are…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today provided a clinical update and focus for its Oncoprex(TM) immunogene therapy program for 2020. According to the update, Genprex will prioritize the development of Oncoprex in combination with osimertinib for the…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced its plans to host a virtual roadshow webinar at 4:30 PM ET on Thursday, February 6, 2020. According to the update, Sigma Labs newly appointed Executive Chairman Mark K. Ruport and CEO John Rice will be…
Predictive Oncology (NASDAQ: POAI), together with its subsidiary, TumorGenesis, Inc., today announced that it has selected US Biological Corporation of Salem, Massachusetts as the manufacturer and distributor of its innovative culture media for growing ovarian tumor cells. TumorGenesis media are specially formulated to help researchers isolate and maintain the unique histological and basic biological signatures…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly-owned subsidiary of the company, has amended the terms of its recent US$10 million loan to TerrAscend Canada Inc., a wholly‑owned subsidiary of TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF). The loan, announced October 2,…
Jerrick Media Holdings (OTCQB: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality, recently published a weekly update from the company’s CEO Jeremy Frommer. Among other highlights, Frommer discussed the company’s continued pursuit to expand its talented team. “We are always looking to expand our talented team.…
SRAX (NASDAQ: SRAX) today announced the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. During the interview, SRAX CEO Chris Miglino joins NNW’s Stuart Smith to discuss the company’s milestone achievements and strategic positioning. “Last year was…
Sigma Labs Inc. (NASDAQ: SGLB) CEO John Rice was featured in an article published Monday by Barron’s. The article, titled ‘3-D Printing Is Making Gains in Unexpected Places, Like Cars and Artificial Knees’, evaluates the advancement of 3-D printing, or additive manufacturing, in a number of diverse industries, including automotive production and health care. Rice…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that it will present at the Noble Capital Markets 16th Annual Investor Conference. Genprex’s presentation is scheduled to take place at 1:30 p.m. EST on Monday, February 17, 2020, at…
Digital-marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX) recently revealed results from its 2019 Holiday Spending Report (http://ibn.fm/1KD3A). SRAX COO Kristoffer Nelson said the survey of 116,000 American consumers confirms the power of its proprietary BIGtoken platform. An article discussing the company reads, “The survey showed that 28% of American consumers polled planned to holiday…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its unaudited financial results for the fiscal quarter and six months ended June 30, 2019. Among the highlights, BHAT reported* a total revenue increase of 74.6% year-on-year to…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been invited to present at the Imperial Capital Advanced Manufacturing & Supply Chain Conference. According to the update, the event is slated to be held at the Hyatt Regency in Huntington Beach, California…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its plans to release a benchtop, R&D scale, Ultra Shear Technology(TM) (“UST”)-based BaroShear instrument to the market in the third quarter of 2020. Per…
Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) 2.0 version of its patented DehydraTECH(TM) oral drug-delivery technology has demonstrated its power to deliver more cannabidiol (“CBD”) into the bloodstream than generic industry-control formulations (http://ibn.fm/Utl7A). An article discussing the company reads, “The company’s 2.0 technology is specifically being developed for effectiveness in helping to deliver its drug payload…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that, in a recent study, independent researchers reported that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex(TM) immunogene therapy, is a potential target and biomarker for…
Predictive Oncology (NASDAQ: POAI), a data and artificial-intelligence- (“AI”) driven, discovery-services company, possesses a unique advantage over its competition in the form of samples and access to historical data on clinical outcomes. This data could enable POAI to produce value to pharmaceutical companies significantly faster than its competitors. An article discussing the company reads, “Specifically,…
Jerrick Media Holdings (OTC: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality, recently published a weekly update from the company’s CEO Jeremy Frommer. In the update, Frommer discussed the company’s stock performance as it gets closer to the uplist and its progress on multiple fronts, including…